Europe — EMA
Paracetamol
Paracetamol, the active ingredient in Paracetamol, is an analgesic presented as an intravenous injection for use in the central nervous system.
Request sourcing
What is Paracetamol?
Paracetamol, the active ingredient in Paracetamol, is an analgesic presented as an intravenous injection for use in the central nervous system. It is employed to relieve pain and reduce fever, particularly in postoperative patients and other individuals requiring rapid antipyretic and analgesic effects. It is commonly administered in hospital settings under medical supervision.\n\nGNH India supplies Paracetamol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and procurement teams worldwide. Our distribution network ensures reliable delivery and compliance with regulatory standards across multiple regions.
What is Paracetamol used for?
Paracetamol is used to manage pain and fever by acting on central prostaglandin pathways.\n\n- Pain: Provides analgesic relief for mild to moderate pain, including headache, musculoskeletal discomfort, dental pain, and postoperative pain, improving patient comfort.\n- Fever: Reduces elevated body temperature associated with infections, inflammatory conditions, or postoperative febrile responses, helping to normalize thermoregulation.\n- Postoperative analgesia: Offers rapid antipyretic and analgesic effects when administered intravenously after surgical procedures, supporting early recovery and pain management.\n- Fever in children: Provides safe and effective temperature reduction for pediatric patients with febrile illnesses, under medical supervision.
What are the side effects of Paracetamol?
Paracetamol may be associated with adverse reactions, most of which are mild and reversible.\n\nCommon Side Effects:\n- Nausea: Mild nausea or stomach discomfort may occur, usually transient and self‑limiting.\n- Rash: Transient skin rash or mild itching may appear, often resolving without treatment.\n- Elevated liver enzymes: Small increases in hepatic transaminases without clinical symptoms, typically observed in routine lab monitoring.\n- Injection site reactions: Redness, swelling,



